{
    "Trade/Device Name(s)": [
        "POPS! one Blood Glucose Monitoring System"
    ],
    "Submitter Information": "TaiDoc Technology Corporation",
    "510(k) Number": "K181588",
    "Predicate Device Reference 510(k) Number(s)": [
        "K100322"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW"
    ],
    "Summary Letter Date": "November 30, 2018",
    "Summary Letter Received Date": "October 31, 2018",
    "Submission Date": "November 30, 2018",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood (finger)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "POPS! one blood glucose meter",
        "POPS! mobile application"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Amperometric glucose biosensor"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Sensor module",
        "Mobile application"
    ],
    "Document Summary": "FDA 510(k) summary for the POPS! one Blood Glucose Monitoring System using an electrochemical biosensor and integrated mobile app for self-monitoring blood glucose at home.",
    "Indications for Use Summary": "For quantitative measurement of glucose in fresh capillary whole blood from the finger, used by people with diabetes mellitus at home as an aid in monitoring the effectiveness of a diabetes control program; single-patient use only, not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}